198 related articles for article (PubMed ID: 11396629)
1. CD99 immunoreactivity in ependymoma.
Choi YL; Chi JG; Suh YL
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):125-9. PubMed ID: 11396629
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of CD99 and EMA expression in ependymomas.
Mahfouz S; Aziz AA; Gabal SM; el-Sheikh S
Medscape J Med; 2008 Feb; 10(2):41. PubMed ID: 18382710
[TBL] [Abstract][Full Text] [Related]
3. Olig2 and CD99 are useful negative markers for the diagnosis of brain tumors.
Ishizawa K; Komori T; Shimada S; Hirose T
Clin Neuropathol; 2008; 27(3):118-28. PubMed ID: 18552083
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors.
Figarella-Branger D; Lepidi H; Poncet C; Gambarelli D; Bianco N; Rougon G; Pellissier JF
Acta Neuropathol; 1995; 89(3):248-57. PubMed ID: 7754745
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of Olig2, CD99, and EMA to differentiate oligodendroglial-like neoplasms.
Kurdi M; Eberhart C
Folia Neuropathol; 2021; 59(3):284-290. PubMed ID: 34628794
[TBL] [Abstract][Full Text] [Related]
6. A Comparative Immunohistochemical Study of Epithelial Membrane Antigen and NHERF1/EBP50 in the Diagnosis of Ependymomas.
Nambirajan A; Sharma MC; Rajeshwari M; Kakkar A; Suri V; Sarkar C
Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):71-78. PubMed ID: 27753657
[TBL] [Abstract][Full Text] [Related]
7. SOX10 and Olig2 as negative markers for the diagnosis of ependymomas: An immunohistochemical study of 98 glial tumors.
Švajdler M; Rychlý B; Mezencev R; Fröhlichová L; Bednárová A; Pataky F; Daum O
Histol Histopathol; 2016 Jan; 31(1):95-102. PubMed ID: 26287936
[TBL] [Abstract][Full Text] [Related]
8. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
9. Extracerebellar primitive neuroectodermal tumors: A clinicopathologic study with bcl-2 and CD99 immunohistochemistry.
Gyure KA; Prayson RA; Estes ML
Ann Diagn Pathol; 1999 Oct; 3(5):276-80. PubMed ID: 10556473
[TBL] [Abstract][Full Text] [Related]
10. Ependymal and choroid plexus tumors. Cytokeratin and GFAP expression.
Mannoji H; Becker LE
Cancer; 1988 Apr; 61(7):1377-85. PubMed ID: 2449946
[TBL] [Abstract][Full Text] [Related]
11. Comparative immunohistochemical study of insulin-like growth factor II and insulin-like growth factor receptor type 1 in pediatric brain tumors.
Ogino S; Kubo S; Abdul-Karim FW; Cohen ML
Pediatr Dev Pathol; 2001; 4(1):23-31. PubMed ID: 11200487
[TBL] [Abstract][Full Text] [Related]
12. CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin.
Nicholson SA; McDermott MB; Swanson PE; Wick MR
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):37-41. PubMed ID: 10937047
[TBL] [Abstract][Full Text] [Related]
13. CD99 reactivity in mesenchymal chondrosarcoma.
Granter SR; Renshaw AA; Fletcher CD; Bhan AK; Rosenberg AE
Hum Pathol; 1996 Dec; 27(12):1273-6. PubMed ID: 8958297
[TBL] [Abstract][Full Text] [Related]
14. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases.
Jimenez RE; Folpe AL; Lapham RL; Ro JY; O'Shea PA; Weiss SW; Amin MB
Am J Surg Pathol; 2002 Mar; 26(3):320-7. PubMed ID: 11859203
[TBL] [Abstract][Full Text] [Related]
15. Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype.
Suri VS; Tatke M; Singh D; Sharma A
Indian J Cancer; 2004; 41(2):66-71. PubMed ID: 15318011
[TBL] [Abstract][Full Text] [Related]
16. Light microscopic demonstration of the microlumen of ependymoma: a study of the usefulness of antigen retrieval for epithelial membrane antigen (EMA) immunostaining.
Kawano N; Yasui Y; Utsuki S; Oka H; Fujii K; Yamashina S
Brain Tumor Pathol; 2004; 21(1):17-21. PubMed ID: 15696964
[TBL] [Abstract][Full Text] [Related]
17. Antineuronal nuclei immunohistochemical staining patterns in childhood ependymomas.
Parker JR; Armstrong DL; Strother D; Rudman DM; Dauser RC; Laurent JP; Deyd J; Rouah PE
J Child Neurol; 2001 Aug; 16(8):548-52. PubMed ID: 11510923
[TBL] [Abstract][Full Text] [Related]
18. [Diagnostic use of D2-40 and annexin-1 in ependymal tumors].
Wang YF; Piao YS; Lu DH; Chen L; Wang W; Yang H; Wei LF
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):595-8. PubMed ID: 22177242
[TBL] [Abstract][Full Text] [Related]
19. Stromal cells in hemangioblastoma: neuroectodermal differentiation and morphological similarities to ependymoma.
Ishizawa K; Komori T; Hirose T
Pathol Int; 2005 Jul; 55(7):377-85. PubMed ID: 15982211
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
